Posts Tagged ‘KTT’

Tuesday May 02nd, 2017

FreeOx Biotech acquires the rights of two compounds to treat neurological and cardiovascular diseases

Dr. Ángel Chamorro, Head of the Functional Unit of Cerebral Vascular Pathology at Hospital Clínic de Barcelona, ​​has developed two compounds with neuroprotective properties based on reducing the effects of oxidative stress on the body. Hospital Clínic and the Clínic Foundation for Biomedical Research, with the support of the IDIBAPS’s KTT office (Knowledge and Technology Transfer), have signed an exclusive license agreement with FreeOx Biotech for the development and exploitation of this technology. Read the rest of this entry »

Comments Closed
Monday March 27th, 2017

The IDIBAPS participates in BIO-Europe Spring

The Barcelona International Convention Center hosted from 20-22 March the BIO-Europe Spring conference. This is the most important partnering congress in Europe for the biotechnology and pharmaceutical industry. Attendees had 3 days to hold 30-minute private meetings with other international managers and business developers, from other institutions and companies around the world.

Read the rest of this entry »

Comments Closed


Posted in:

Monday October 10th, 2016

The Knowledge and Technology Transfer office of IDIBAPS at the Biospain meeting

From 28 to 30 September was held in Bilbao the 8th edition of BioSpain, a meeting that involves pharma and biotech companies and organizations. BioSpain provides a space for identifying potential partners and lectures, presentations of companies, investment forums are made, and provides a forum for training and work. In this edition 615 companies have participated, 30% of which are international. The Catalan delegation has had the participation of 90companies and public institutions.

Read the rest of this entry »

Comments Closed